More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.
Atalay Goshu MulunehMehari Woldemariam MeridKassahun Alemu GelayeSewbesew Yitayih TilahunNahom Worku TeshagerAklilu Yiheyis AberehaKalkidan Samuel SugamoMulugeta Ayalew YimerGetahun Molla KassaPublished in: Infection and drug resistance (2022)
Adverse event following immunization has been a public health problem in Northwest Ethiopia. Being female and having a feeling that the vaccine is unsafe were statistically significantly associated with AEFI.